ストックスクリーナーアプリを入手
8.72
8.60%
-0.82
前日終値:
$9.54
開ける：
$9.47
24時間の取引高:
1.55M
Relative Volume:
0.99
時価総額：
$741.76M
収益：
-
当期純損益:
$-43.16M
株価収益率:
-15.85
EPS:
-0.55
ネットキャッシュフロー:
$-29.31M
1週間 パフォーマンス:
-10.47%
1か月 パフォーマンス:
+11.08%
6か月 パフォーマンス:
+53.52%
1年 パフォーマンス:
+71.32%
1日の値動き範囲:
$8.63
$9.5296
1週間の範囲:
$8.63
$9.9692
52週間の値動き範囲:
$3.25
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
名前
Anavex Life Sciences Corporation
セクター
電話
844-689-3939
住所
630 5TH AVENUE, NEW YORK
AVXL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
8.72 | 741.76M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-12-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-09-23 | 開始されました | BTIG Research | Buy |
| 2020-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-28 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-02-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-18 | 開始されました | Janney | Buy |
| 2018-05-16 | 再開されました | Maxim Group | Buy |
| 2018-03-08 | 開始されました | ROTH Capital | Buy |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
| 2017-09-29 | 再開されました | Noble Financial | Buy |
| 2017-02-07 | 開始されました | Noble Financial | Buy |
| 2016-03-29 | 開始されました | FBR Capital | Outperform |
すべてを表示
Anavex Life Sciences Corporation (AVXL) 最新ニュース
19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Acquired by Proficio Capital Partners LLC - Defense World
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
Charles Schwab Investment Management Inc. Purchases 11,239 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Bank of New York Mellon Corp Has $2.37 Million Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL - Business Wire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Atria Investments Inc - Defense World
Proficio Capital Partners LLC Purchases New Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Did Anavex Life Sciences Corp. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- AVXL - ACCESS Newswire
Anavex Life Sciences Corp. to Host Earnings Call - ACCESS Newswire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stake Raised by Rhumbline Advisers - Defense World
Private Advisor Group LLC Sells 17,488 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
IMMINENT AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Y Intercept Hong Kong Ltd Makes New $243,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 – AVXL - ACCESS Newswire
Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineAVXL - ACCESS Newswire
Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
27,052 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Bought by Atria Wealth Solutions Inc. - Defense World
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders - ACCESS Newswire
AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
D.A. Davidson & CO. Buys Shares of 11,385 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Contrasting Cortexyme (NASDAQ:CRTX) and Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future - Yahoo Finance
Levi & Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024AVXL - ACCESS Newswire
When Will Anavex Life Sciences Corp. (NASDAQ:AVXL) Breakeven? - Simply Wall St
Shareholders that lost money on Anavex Life Sciences Corporation (AVXL) should contact Levi & Korsinsky about pending Class ActionAVXL - ACCESS Newswire
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference - The Manila Times
Can Anavex's Neurology Pipeline Transform Alzheimer's Treatment? CEO Presents Latest Progress - StockTitan
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from HC Wainwright - MarketBeat
Brokers Issue Forecasts for AVXL Q1 Earnings - Defense World
UPCOMING AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit - ACCESS Newswire
Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at HC Wainwright - Defense World
Wainwright maintains $42 target on Anavex Life Sciences stock By Investing.com - Investing.com Nigeria
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Wainwright maintains $42 target on Anavex Life Sciences stock - Investing.com
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Shareholders of Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Anavex Life Sciences (NASDAQ:AVXL) Posts Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Earnings call transcript: Anavex Life Sciences Q4 2024 sees net loss, stock rises - MSN
Anavex: Looking At Different Statistical Approaches Before EMA Opinion (NASDAQ:AVXL) - Seeking Alpha
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Call Transcript - MSN
Anavex Life Sciences Reports Higher Quarterly Loss Amid R&D Focus - TipRanks
Anavex Life Sciences Corporation (AVXL) 財務データ
収益
当期純利益
現金流量
EPS
Anavex Life Sciences Corporation (AVXL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Donhauser Peter D.O. | Director |
Jun 14 '24 |
Buy |
3.64 |
2,835 |
10,319 |
5,000 |
| Thomas Steffen | Director |
May 15 '24 |
Buy |
4.52 |
5,000 |
22,600 |
5,000 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):